Stethescope and money

According to the National Diabetes Statistics Report by the Center for Disease Control and Prevention, Hyperglycemia and diabetes in the hospital setting affect 38% to 46% of non-critically ill hospitalized patients. With diabetes and hyperglycemia increasing in our society, increased morbidity, length of stay in the ICU and in the hospital, and higher infection rates and more ventilator days also continue to skyrocket.

What does this mean to the average healthcare provider? Dollar signs.

According to The Centers for Medicare and Medicaid Services, complications arising from suboptimal blood glucose levels are viewed as a Hospital Acquired Condition – adding to treatment expenses. Minimizing the length of stay in the ICU and hospital overall reduces costs, decreases infections and other complications as part of a glycemic management program.

A glucose management software, such as EndoTool, replaces linear inpatient insulin protocols with clinical decision support for safe and personalized treatment.

The EndoTool software has helped providers obtain the following results:

  • 99.4% achieve control
  • 95% less hypoglycemia
  • 61% HAC reduction
  • 46% fewer blood glucose level checks

Implementing a glucose management solution for any clinical scenario where insulin is administered to hospitalized patients, will help you mitigate risks and reduce costs. Save your hospital money today!